These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18974783)

  • 21. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.
    Vocke CD; Yang Y; Pavlovich CP; Schmidt LS; Nickerson ML; Torres-Cabala CA; Merino MJ; Walther MM; Zbar B; Linehan WM
    J Natl Cancer Inst; 2005 Jun; 97(12):931-5. PubMed ID: 15956655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
    Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M
    Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus.
    Starink TM; Houweling AC; van Doorn MB; Leter EM; Jaspars EH; van Moorselaar RJ; Postmus PE; Johannesma PC; van Waesberghe JH; Ploeger MH; Kramer MT; Gille JJ; Waisfisz Q; Menko FH
    J Am Acad Dermatol; 2012 Feb; 66(2):259.e1-9. PubMed ID: 21794948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer.
    Bartram MP; Mishra T; Reintjes N; Fabretti F; Gharbi H; Adam AC; Göbel H; Franke M; Schermer B; Haneder S; Benzing T; Beck BB; Müller RU
    BMC Med Genet; 2017 May; 18(1):53. PubMed ID: 28499369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Birt-Hogg-Dubé syndrome: clinical and genetic studies of 10 French families.
    Kluger N; Giraud S; Coupier I; Avril MF; Dereure O; Guillot B; Richard S; Bessis D
    Br J Dermatol; 2010 Mar; 162(3):527-37. PubMed ID: 19785621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Birt-Hogg-Dubé syndrome with clear-cell and oncocytic renal tumour and trichoblastoma associated with a novel FLCN mutation.
    Imada K; Dainichi T; Yokomizo A; Tsunoda T; Song YH; Nagasaki A; Sawamura D; Nishie W; Shimizu H; Fukagawa S; Urabe K; Furue M; Hashimoto T; Naito S
    Br J Dermatol; 2009 Jun; 160(6):1350-3. PubMed ID: 19416240
    [No Abstract]   [Full Text] [Related]  

  • 27. Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?
    Johannesma PC; Houweling AC; Menko FH; van de Beek I; Reinhard R; Gille JJ; van Waesberghe JT; Thunnissen E; Starink TM; Postmus PE; van Moorselaar RJ
    Fam Cancer; 2016 Apr; 15(2):297-300. PubMed ID: 26603437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
    Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Birt Hogg Dube syndrome and cancer predisposition.
    Palmirotta R; Savonarola A; Ludovici G; Donati P; Cavaliere F; DE Marchis ML; Ferroni P; Guadagni F
    Anticancer Res; 2010 Mar; 30(3):751-7. PubMed ID: 20392993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
    Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
    Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Birt-Hogg-Dubé syndrome].
    Koga S; Furuya M; Nakatani Y
    Nihon Rinsho; 2010 Feb; 68(2):361-9. PubMed ID: 20158110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.
    Hong SB; Oh H; Valera VA; Stull J; Ngo DT; Baba M; Merino MJ; Linehan WM; Schmidt LS
    Mol Cancer; 2010 Jun; 9():160. PubMed ID: 20573232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2.
    Hasumi Y; Baba M; Ajima R; Hasumi H; Valera VA; Klein ME; Haines DC; Merino MJ; Hong SB; Yamaguchi TP; Schmidt LS; Linehan WM
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18722-7. PubMed ID: 19850877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.
    Schneider M; Dinkelborg K; Xiao X; Chan-Smutko G; Hruska K; Huang D; Sagar P; Harisinghani M; Iliopoulos O
    Fam Cancer; 2018 Jan; 17(1):135-139. PubMed ID: 28623476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
    Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
    Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.
    Zbar B; Alvord WG; Glenn G; Turner M; Pavlovich CP; Schmidt L; Walther M; Choyke P; Weirich G; Hewitt SM; Duray P; Gabril F; Greenberg C; Merino MJ; Toro J; Linehan WM
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):393-400. PubMed ID: 11927500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dubé patients.
    van Steensel MA; Verstraeten VL; Frank J; Kelleners-Smeets NW; Poblete-Gutiérrez P; Marcus-Soekarman D; Bladergroen RS; Steijlen PM; van Geel M
    J Invest Dermatol; 2007 Mar; 127(3):588-93. PubMed ID: 17124507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.